Titre : Complications hématologiques de la grossesse

Complications hématologiques de la grossesse : Questions médicales fréquentes

Termes MeSH sélectionnés :

Randomized Controlled Trials as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Complications hématologiques de la grossesse : Questions médicales les plus fréquentes", "headline": "Complications hématologiques de la grossesse : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Complications hématologiques de la grossesse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-07", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Complications hématologiques de la grossesse" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hémopathies", "url": "https://questionsmedicales.fr/mesh/D006402", "about": { "@type": "MedicalCondition", "name": "Hémopathies", "code": { "@type": "MedicalCode", "code": "D006402", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C15.378" } } }, "about": { "@type": "MedicalCondition", "name": "Complications hématologiques de la grossesse", "alternateName": "Pregnancy Complications, Hematologic", "code": { "@type": "MedicalCode", "code": "D011250", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Wilma Barcellini", "url": "https://questionsmedicales.fr/author/Wilma%20Barcellini", "affiliation": { "@type": "Organization", "name": "Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy." } }, { "@type": "Person", "name": "Bruno Fattizzo", "url": "https://questionsmedicales.fr/author/Bruno%20Fattizzo", "affiliation": { "@type": "Organization", "name": "Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy." } }, { "@type": "Person", "name": "Nihar R Nayak", "url": "https://questionsmedicales.fr/author/Nihar%20R%20Nayak", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, UMKC School of Medicine, Kansas City, MO 64108, USA." } }, { "@type": "Person", "name": "Katherine E Economy", "url": "https://questionsmedicales.fr/author/Katherine%20E%20Economy", "affiliation": { "@type": "Organization", "name": "Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA." } }, { "@type": "Person", "name": "Anne Marie Valente", "url": "https://questionsmedicales.fr/author/Anne%20Marie%20Valente", "affiliation": { "@type": "Organization", "name": "Department of Cardiology, Boston Children's Hospital, Boston, MA, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A randomized controlled trial evaluating the effects of motivational interviewing in new hearing aid users (MI-HAT): study protocol for a randomized controlled trial.", "datePublished": "2023-05-22", "url": "https://questionsmedicales.fr/article/37217960", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-023-07352-7" } }, { "@type": "ScholarlyArticle", "name": "Protocol for a randomized controlled trial: exercise-priming of CBT for depression (the CBT+ trial).", "datePublished": "2024-10-07", "url": "https://questionsmedicales.fr/article/39375728", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-024-08495-x" } }, { "@type": "ScholarlyArticle", "name": "Understanding explanatory and pragmatic trials: Examples from randomized controlled trials on vertebroplasty.", "datePublished": "2022-12-23", "url": "https://questionsmedicales.fr/article/36566693", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neuchi.2022.101403" } }, { "@type": "ScholarlyArticle", "name": "Emulating Randomized Controlled Trials with Hybrid Control Arms in Oncology: A Case Study.", "datePublished": "2023-01-22", "url": "https://questionsmedicales.fr/article/36606735", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cpt.2841" } }, { "@type": "ScholarlyArticle", "name": "Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35804404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13063-022-06365-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Hémopathies et maladies lymphatiques", "item": "https://questionsmedicales.fr/mesh/D006425" }, { "@type": "ListItem", "position": 3, "name": "Hémopathies", "item": "https://questionsmedicales.fr/mesh/D006402" }, { "@type": "ListItem", "position": 4, "name": "Complications hématologiques de la grossesse", "item": "https://questionsmedicales.fr/mesh/D011250" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Complications hématologiques de la grossesse - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Complications hématologiques de la grossesse", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Complications hématologiques de la grossesse", "description": "Comment diagnostiquer une anémie pendant la grossesse ?\nQuels tests pour la thrombocytopénie chez la femme enceinte ?\nComment détecter un trouble de la coagulation ?\nQuels signes indiquent une complication hématologique ?\nQuand faire un dépistage de la thalassémie ?", "url": "https://questionsmedicales.fr/mesh/D011250?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Complications hématologiques de la grossesse", "description": "Quels sont les symptômes de l'anémie chez la femme enceinte ?\nComment reconnaître une thrombocytopénie ?\nQuels signes d'alerte pour les troubles de la coagulation ?\nQuels symptômes d'une carence en fer ?\nComment se manifeste une hypercoagulabilité ?", "url": "https://questionsmedicales.fr/mesh/D011250?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Complications hématologiques de la grossesse", "description": "Comment prévenir l'anémie pendant la grossesse ?\nQuelles mesures pour éviter la thrombocytopénie ?\nComment réduire le risque de troubles de la coagulation ?\nQuels conseils nutritionnels pour prévenir les carences ?\nComment surveiller les facteurs de risque hématologiques ?", "url": "https://questionsmedicales.fr/mesh/D011250?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Complications hématologiques de la grossesse", "description": "Quel traitement pour l'anémie pendant la grossesse ?\nComment traiter la thrombocytopénie ?\nQuels médicaments pour les troubles de la coagulation ?\nComment gérer une carence en vitamine B12 ?\nQuel suivi pour les femmes avec des troubles hématologiques ?", "url": "https://questionsmedicales.fr/mesh/D011250?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Complications hématologiques de la grossesse", "description": "Quelles complications peuvent survenir avec l'anémie ?\nQuels risques associés à la thrombocytopénie ?\nComment les troubles de la coagulation affectent-ils la grossesse ?\nQuelles sont les conséquences d'une carence en fer ?\nQuels impacts des troubles hématologiques sur le fœtus ?", "url": "https://questionsmedicales.fr/mesh/D011250?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Complications hématologiques de la grossesse", "description": "Quels facteurs augmentent le risque d'anémie ?\nQuels sont les facteurs de risque pour la thrombocytopénie ?\nComment l'âge influence-t-il les complications hématologiques ?\nQuels antécédents médicaux sont préoccupants ?\nQuel rôle joue la génétique dans les complications hématologiques ?", "url": "https://questionsmedicales.fr/mesh/D011250?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anémie pendant la grossesse ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic d'anémie se fait par une prise de sang mesurant l'hémoglobine et l'hématocrite." } }, { "@type": "Question", "name": "Quels tests pour la thrombocytopénie chez la femme enceinte ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un hémogramme complet est nécessaire pour évaluer le nombre de plaquettes sanguines." } }, { "@type": "Question", "name": "Comment détecter un trouble de la coagulation ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de coagulation comme le temps de prothrombine et le temps de thromboplastine partielle sont utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une complication hématologique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des saignements, des ecchymoses ou une fatigue excessive peuvent indiquer une complication." } }, { "@type": "Question", "name": "Quand faire un dépistage de la thalassémie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le dépistage de la thalassémie est recommandé lors des consultations prénatales, surtout en cas d'antécédents familiaux." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'anémie chez la femme enceinte ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, pâleur, essoufflement et palpitations." } }, { "@type": "Question", "name": "Comment reconnaître une thrombocytopénie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements inhabituels, des ecchymoses et des saignements de nez fréquents peuvent indiquer une thrombocytopénie." } }, { "@type": "Question", "name": "Quels signes d'alerte pour les troubles de la coagulation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements prolongés après une coupure ou des hématomes fréquents peuvent être des signes d'alerte." } }, { "@type": "Question", "name": "Quels symptômes d'une carence en fer ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, faiblesse, et parfois des envies de manger des substances non alimentaires." } }, { "@type": "Question", "name": "Comment se manifeste une hypercoagulabilité ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par des douleurs dans les jambes, un gonflement ou des rougeurs." } }, { "@type": "Question", "name": "Comment prévenir l'anémie pendant la grossesse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en fer et des suppléments peuvent aider à prévenir l'anémie." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la thrombocytopénie ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les médicaments qui affectent les plaquettes et surveiller les infections peut aider." } }, { "@type": "Question", "name": "Comment réduire le risque de troubles de la coagulation ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une activité physique régulière et éviter le tabagisme peut réduire le risque." } }, { "@type": "Question", "name": "Quels conseils nutritionnels pour prévenir les carences ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Consommer des aliments riches en fer, folates et vitamines est crucial pour prévenir les carences." } }, { "@type": "Question", "name": "Comment surveiller les facteurs de risque hématologiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et des tests sanguins peuvent aider à surveiller les facteurs de risque." } }, { "@type": "Question", "name": "Quel traitement pour l'anémie pendant la grossesse ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut des suppléments de fer et une alimentation riche en fer." } }, { "@type": "Question", "name": "Comment traiter la thrombocytopénie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la cause, mais peut inclure des transfusions de plaquettes si nécessaire." } }, { "@type": "Question", "name": "Quels médicaments pour les troubles de la coagulation ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des anticoagulants peuvent être prescrits pour prévenir les complications thromboemboliques." } }, { "@type": "Question", "name": "Comment gérer une carence en vitamine B12 ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des injections de vitamine B12 ou des suppléments oraux peuvent être nécessaires." } }, { "@type": "Question", "name": "Quel suivi pour les femmes avec des troubles hématologiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier avec des tests sanguins est essentiel pour surveiller l'évolution." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'anémie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "L'anémie peut entraîner des complications comme un faible poids à la naissance et une fatigue accrue." } }, { "@type": "Question", "name": "Quels risques associés à la thrombocytopénie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La thrombocytopénie peut augmenter le risque de saignements graves pendant l'accouchement." } }, { "@type": "Question", "name": "Comment les troubles de la coagulation affectent-ils la grossesse ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent entraîner des complications comme des thromboses veineuses profondes et des hémorragies." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une carence en fer ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une carence en fer peut causer des complications comme une fatigue extrême et des problèmes de développement fœtal." } }, { "@type": "Question", "name": "Quels impacts des troubles hématologiques sur le fœtus ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent affecter la croissance fœtale et augmenter le risque de prématurité." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'anémie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent une alimentation pauvre en fer, des grossesses multiples et des antécédents d'anémie." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour la thrombocytopénie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents médicaux, certaines infections et des médicaments peuvent augmenter le risque." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il les complications hématologiques ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes plus âgées peuvent avoir un risque accru de complications hématologiques pendant la grossesse." } }, { "@type": "Question", "name": "Quels antécédents médicaux sont préoccupants ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents de troubles sanguins, comme la drépanocytose, augmentent le risque de complications." } }, { "@type": "Question", "name": "Quel rôle joue la génétique dans les complications hématologiques ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents familiaux de troubles sanguins peuvent prédisposer à des complications hématologiques." } } ] } ] }

Sources (10000 au total)

A randomized controlled trial evaluating the effects of motivational interviewing in new hearing aid users (MI-HAT): study protocol for a randomized controlled trial.

Hearing loss is the third leading global cause of disability and is associated with poorer quality of life. Hearing aids are often recommended for hearing loss; however, hearing aid uptake and use rat... A multi-center, prospective, randomized patient-blind controlled trial with a pre- and post-tests design. New hearing aid users ≥ 18 years of age will be recruited from Vancouver, Canada. They will be... This trial is designed to evaluate the efficacy of one-on-one MI in improving hearing aid use in new adult users in the short and long terms. Results will contribute to the evidence on whether MI coun... ClinicalTrials.gov NCT04673565 . Registered on 17 December 2020....

Protocol for a randomized controlled trial: exercise-priming of CBT for depression (the CBT+ trial).

Depression is a leading cause of disability worldwide, and treatments could be more effective. Identifying methods to improve treatment success has the potential to reduce disease burden dramatically.... The CBT + trial will be a parallel-arm randomized controlled trial that will recruit 40 adult participants with DSM-5 diagnosed depression (verified with clinical interview) via referrals, mass emails... The novel approach of priming CBT with moderate-intensity aerobic exercise evaluated in a randomized controlled trial (CBT + trial) has the potential to demonstrate the usefulness of exercise as an au... ClinicalTrials.gov NCT06001346 . Registered on August 21, 2023....

Understanding explanatory and pragmatic trials: Examples from randomized controlled trials on vertebroplasty.

To better understand the explanatory-pragmatic distinction in the design and interpretation of randomized controlled trials (RCTs).... We review the explanatory-pragmatic distinction in clinical trial design. We use the PRECIS-2 tool to evaluate the trial design of selected RCTs on percutaneous vertebroplasty for osteoporotic vertebr... The selection of criteria and the scoring of multiple PRECIS domains were subjective and thus debatable. The pragmascope patterns of various vertebroplasty trials were heterogeneous. Many trials had b... The results of a trial cannot be interpreted without understanding the various design choices made along the explanatory-pragmatic spectrum....

Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.

Lingual microcystic lymphatic malformations (LMLMs) are rare congenital vascular malformations presenting as clusters of cysts filled with lymph fluid or blood. Even small well-limited lesions can be ... This is a randomized, multicentric study using an individually randomized stepped-wedge design over 24 weeks to evaluate topical application of a 1 mg/mL sirolimus solution once daily, on LMLM, versus... Given the disappointing state of current treatment options in LMLMs, topical sirolimus could become firstline therapy in treating LMLMs if its efficacy and safety were to be demonstrated.... ClinicalTrials.gov NCT04128722 . Registered on 24 September 2019. EudraCT: EUCTR2019-001530-33-FR Sponsor (University Hospital Center of Tours - CHRU Tours): DR190041-TOPGUN French regulatory authorit...

Ayurveda Management of Allergic Rhinitis: Protocol for a Randomized Controlled Trial.

Allergic rhinitis (AR) is the inflammation of the membranes lining the nose due to allergen exposure and is characterized by sneezing, nasal congestion, itching of the nose, or postnasal discharge. Th... The primary aim is to assess the efficacy of Ayurvedic management for AR (or vataja pratishyaya) by comparing it to a conventional control group. The secondary aims are to determine the mean change in... This ongoing study is an open-label randomized controlled interventional trial, with a sample size of 90 both in the trial and standard control group (including dropouts, 20%), and will be carried out... As of May 2024, 72 patients have been enrolled in both groups. Data analysis should be completed by February 2025. The study will be reported following standard guidelines for reporting randomized con... The Ayurvedic approach could be an evidence-based therapeutic tactic for the management of AR.... Clinical Trials Registry India CTRI/2023/06/053395; https://tinyurl.com/564d2zz8.... DERR1-10.2196/56063....

Scandinavian trial of uncomplicated aortic dissection therapy: study protocol for a randomized controlled trial.

Contemporary management of uncomplicated type B aortic dissections (uTBAD) is based on the acuity and various morphological features. Medical therapy is mandatory, while the risks of early thoracic en... The trial is a randomized, open-label, superiority clinical trial with parallel assignment of subjects at 23 clinical sites in Denmark, Norway, Sweden, Finland, and Iceland. Eligibility includes patie... This trial will evaluate the primary question of whether early TEVAR improves survival at 5 years among uTBAD patients. Moreover, the costs and the impact on quality of life should provide sorely need... ClinicalTrials.gov NCT05215587. Registered on January 31, 2022....

Optimizing tobacco treatment delivery for people with HIV: trial protocol for a randomized controlled trial.

With advances in antiretroviral therapy, people with HIV (PWH) are living longer and are less likely to die from AIDS-related complications. Yet, prior research has shown that smoking is often not add... The current study is a type 1 hybrid effectiveness-implementation trial to evaluate the impact of a proactive, opt-out tobacco treatment intervention on cessation outcomes and advance understanding of... This study will examine a novel approach to optimizing tobacco treatment delivery for PWH. Integrating effectiveness and implementation results will help define best practices for engaging PWH with ev... ClinicalTrials.gov: NCT05019495 (August 24, 2021)....

Acupuncture as Adjuvant Therapy for Glaucoma: Protocol for a Randomized Controlled Trial.

Glaucoma is a chronic progressive optic neuropathy that necessitates lifelong treatment to reduce the decline of the optic nerve. Due to the extended and continuous treatments required for patients, c... The primary objective of this study is to conduct a single-center randomized control trial involving patients with glaucoma. Acupuncture will be evaluated as an adjunctive therapy. The trial aims to e... In this single-center randomized controlled trial, participants (N=50) with primary open-angle glaucoma will be randomly assigned to the treatment group, receiving ophthalmic acupuncture with "De Qi" ... Recruitment of participants for the trial commenced on June 28, 2023. A total of 10 participants have been enrolled to test the feasibility of the experiment. We anticipate that the preliminary data f... This trial uses rigorous methodology and comprehensive outcome measurements to assess the clinical efficacy of acupuncture as an adjunctive therapy for glaucoma, providing valuable insights for future... ClinicalTrials.gov NCT05753137; https://clinicaltrials.gov/study/NCT05753137.... DERR1-10.2196/57888....